163 related articles for article (PubMed ID: 22231830)
1. Interleukin-2 and the septohippocampal system: intrinsic actions and autoimmune processes relevant to neuropsychiatric disorders.
Petitto JM; Huang Z; Meola D; Ha GK; Dauer D
Methods Mol Biol; 2012; 829():433-43. PubMed ID: 22231830
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-2 and the brain: dissecting central versus peripheral contributions using unique mouse models.
Petitto JM; Meola D; Huang Z
Methods Mol Biol; 2012; 934():301-11. PubMed ID: 22933152
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 and the Septohippocampal System: An Update on Intrinsic Actions and Autoimmune Processes Relevant to Neuropsychiatric Disorders.
El Hayek S; Allouch F; Geagea L; Talih F
Methods Mol Biol; 2019; 2011():511-530. PubMed ID: 31273719
[TBL] [Abstract][Full Text] [Related]
4. Connection between inflammatory processes and transmittor function-Modulatory effects of interleukin-1.
Spulber S; Schultzberg M
Prog Neurobiol; 2010 Feb; 90(2):256-62. PubMed ID: 19853010
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune pathology accounts for common manifestations in a wide range of neuro-psychiatric disorders: the olfactory and immune system interrelationship.
Moscavitch SD; Szyper-Kravitz M; Shoenfeld Y
Clin Immunol; 2009 Mar; 130(3):235-43. PubMed ID: 19097945
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6, a mental cytokine.
Spooren A; Kolmus K; Laureys G; Clinckers R; De Keyser J; Haegeman G; Gerlo S
Brain Res Rev; 2011 Jun; 67(1-2):157-83. PubMed ID: 21238488
[TBL] [Abstract][Full Text] [Related]
7. Changes in hippocampal IL-15, related cytokines, and neurogenesis in IL-2 deficient mice.
Beck RD; Wasserfall C; Ha GK; Cushman JD; Huang Z; Atkinson MA; Petitto JM
Brain Res; 2005 Apr; 1041(2):223-30. PubMed ID: 15829231
[TBL] [Abstract][Full Text] [Related]
8. Lymphocytes in neuroprotection, cognition and emotion: is intolerance really the answer?
Rook GA; Lowry CA; Raison CL
Brain Behav Immun; 2011 May; 25(4):591-601. PubMed ID: 21167931
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis: a complicated picture of autoimmunity.
McFarland HF; Martin R
Nat Immunol; 2007 Sep; 8(9):913-9. PubMed ID: 17712344
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10: biology, role in inflammation and autoimmunity.
Lalani I; Bhol K; Ahmed AR
Ann Allergy Asthma Immunol; 1997 Dec; 79(6):469-83. PubMed ID: 9433360
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a cytokine model of cognitive function.
McAfoose J; Baune BT
Neurosci Biobehav Rev; 2009 Mar; 33(3):355-66. PubMed ID: 18996146
[TBL] [Abstract][Full Text] [Related]
12. Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults.
Hagberg H; Gressens P; Mallard C
Ann Neurol; 2012 Apr; 71(4):444-57. PubMed ID: 22334391
[TBL] [Abstract][Full Text] [Related]
13. Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection.
Yaddanapudi K; Hornig M; Serge R; De Miranda J; Baghban A; Villar G; Lipkin WI
Mol Psychiatry; 2010 Jul; 15(7):712-26. PubMed ID: 19668249
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2-knockout mice: a new model to study autoimmunity and self-tolerance.
Horák I
Sb Lek; 1996; 97(1):25-8. PubMed ID: 8711415
[TBL] [Abstract][Full Text] [Related]
15. Immune modulation of learning, memory, neural plasticity and neurogenesis.
Yirmiya R; Goshen I
Brain Behav Immun; 2011 Feb; 25(2):181-213. PubMed ID: 20970492
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
[TBL] [Abstract][Full Text] [Related]
17. Autoimmunity in neuropsychiatric disorders.
Coutinho E; Vincent A
Handb Clin Neurol; 2016; 133():269-82. PubMed ID: 27112682
[TBL] [Abstract][Full Text] [Related]
18. Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis.
Quintana A; Müller M; Frausto RF; Ramos R; Getts DR; Sanz E; Hofer MJ; Krauthausen M; King NJ; Hidalgo J; Campbell IL
J Immunol; 2009 Aug; 183(3):2079-88. PubMed ID: 19597000
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
20. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
Jadidi-Niaragh F; Mirshafiey A
Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
